UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043571
Receipt number R000049760
Scientific Title Development of a remote guidance system and demonstration of improvement for obesity and fatty liver using ICT
Date of disclosure of the study information 2021/03/09
Last modified on 2021/03/09 22:46:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a remote guidance system and demonstration of improvement for obesity and fatty liver using ICT

Acronym

Saku Remote Project (SakuRemo)

Scientific Title

Development of a remote guidance system and demonstration of improvement for obesity and fatty liver using ICT

Scientific Title:Acronym

Saku Remote Project (SakuRemo)

Region

Japan


Condition

Condition

Obesity, fatty liver, prediabetes

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess whether remote nutritional guidance interventions using ICT-based PHR applications and FGM can improve obesity and fatty liver as much as conventional methods without monthly face-to-face outpatient guidance.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Weight change after 6 months (weight loss of at least 7.0%)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

Remote nutritional guidance using ICT-based PHR application and FGM

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who have been diagnosed with obesity
2) written informed consent

Key exclusion criteria

1) Patients who have been diagnosed with diabetes mellitus
2) Patients with a recent eGFR <30 ml/min/1.73m2
3) Patients with drug addiction
4) Patients with carcinoma
5) Patients who have had a myocardial infarction within the past 6 months
6) Patients with severe heart failure of New York Heart Association (NYHA) grade 3 or higher
7) Patients with learning disabilities
8) Patients being treated with anti-obesity drugs
(9) Patients diagnosed with eating disorders
10) Pregnant women, lactating women, and patients with the possibility (intention) of pregnancy
11) Patients with depression requiring inpatient treatment or patients taking antipsychotic medication
(12) Patients who are participating in other clinical research
(13) Other patients who are judged by the medical doctor to be unsuitable for the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Ogata

Organization

Asama General Hospital

Division name

Surgery

Zip code

385-8558

Address

1862-1 Iwamurada, Saku, Nagano

TEL

0267-67-2295

Email

ogatas0520@yahoo.co.jp


Public contact

Name of contact person

1st name Mari
Middle name
Last name Ito

Organization

Chuo University

Division name

Research and Development Initiative Laboratory of Lifestyle-related Disease Prevention System

Zip code

112-8551

Address

1-3-27 Kasuga, Bunkyou, Tokyo

TEL

03-3817-7280

Homepage URL

http://c-faculty.chuo-u.ac.jp/~healthy/saku-remote/

Email

mariito.18x@g.chuo-u.ac.jp


Sponsor or person

Institute

Institute of Nonalcoholic Steatohepatitis Japan

Institute

Department

Personal name



Funding Source

Organization

Institute of Nonalcoholic Steatohepatitis Japan

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asama General Hospital

Address

1862-1 Iwamurada, Saku, Nagano

Tel

0267-67-2295

Email

asama-soumu@city.saku.nagano.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 12 Month 03 Day

Date of IRB

2020 Year 12 Month 21 Day

Anticipated trial start date

2021 Year 03 Month 09 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 03 Month 09 Day

Last modified on

2021 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049760


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name